// company-profile

Allogene Therapeutics, Inc.

ALLO
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Filings81Insiders17
// api This Allogene Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Allogene Therapeutics, Inc. insiders sold $29K across 2 transactions with no open-market purchases.

  • Most active insider: Yoshiyama Annie with 1 transaction totaling $22K.
  • Largest single sale: $22K by Yoshiyama Annie on Apr 21, 2026.

Activity skews bearish — sales outpace buys.

Institutional Ownership

Top 13F-HR holders of Allogene Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$419.6M
QoQ change
+119.2%
Reporting period
2026-03-31
#1
Pfizer Inc
CIK 78003
$49.8M
22.0M shares
#2
TPG GP A, LLC
CIK 1903793
$45.7M
18.7M shares
#3
STATE STREET CORP
CIK 93751
$21.1M
8.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 21, 2026Yoshiyama AnnieALLO
Sale
9,586$2.31$22K
Mar 31, 2026Beneski Benjamin MachinasALLO
Sale
2,867$2.50$7K
Mar 16, 2026Chang David DALLO
Sale
47,763$2.47$118K
Mar 16, 2026Beneski Benjamin MachinasALLO
Sale
4,835$2.47$12K
Mar 2, 2026Beneski Benjamin MachinasALLO
Sale
7,132$2.60$19K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.